Stratégies des grandes firmes pharmaceutiques face aux médicaments génériques. Accumulation vs valorisation du capital-savoir

Nejla Yacoub and Blandine Laperche ()

Innovations, 2010, vol. n° 32, issue 2, 81-107

Keywords: Big Pharma strategies; generic drugs; innovation; knowledge-capital; patents (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=INNO_032_0081 (application/pdf)
http://www.cairn.info/revue-innovations-2010-2-page-81.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:inndbu:inno_032_0081

Access Statistics for this article

More articles in Innovations from De Boeck Université
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().